Results 211 to 220 of about 64,020 (335)

The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice.

Biochemical and Biophysical Research Communications - BBRC, 2011
E. Ogawa, M. Hosokawa, N. Harada, S. Yamane, A. Hamasaki, K. Toyoda, S. Fujimoto, Y. Fujita, K. Fukuda, K. Tsukiyama, Yuichiro Yamada, Y. Seino, N. Inagaki   +12 more
semanticscholar   +1 more source

Real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes: A multi‐site retrospective study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3703-3715, May 2026.
Abstract Aims Despite the established efficacy of tirzepatide in randomised controlled trials, real‐world effectiveness data in Japanese patients remain limited. This study evaluated the real‐world effectiveness and safety of tirzepatide in Japanese patients with type 2 diabetes over 52 weeks.
Yusuke Minakata, Masaki Miura, Nobuhiro Nakatake, Masahiro Masuzawa   +3 more
wiley   +1 more source

The blunted insulin release after exercise and the relationship with gastric inhibitory polypeptide and glucagon-like peptide-1

, 2010
Alison Glidden
openalex   +2 more sources

Food-Dependent Androgen and Cortisol Secretion by a Gastric Inhibitory Polypeptide-Receptor Expressive Adrenocortical Adenoma Leading to Hirsutism and Subclinical Cushing’s Syndrome:In Vivoandin VitroStudies [PDF]

, 2001
Stylianos Tsagarakis, C. Tsigos, V. Vassiliou, Panayoula C. Tsiotra, Harris Pratsinis, Dimitris Kletsas, Panagiotis Trivizas, A. Nikou, Theodoros Mavromatis, Flora Sotsiou, S. Raptis, N. Thalassinos   +11 more
openalex   +1 more source

Incomplete Intestinal Metaplasia in Pyloric Gland Mucosa of Helicobacter pylori‐Naïve Stomachs: A Prospective Multicenter Histopathologic Study

Pathology International, Volume 76, Issue 5, May 2026.
In Helicobacter pylori (Hp)–naïve stomachs, although mild atrophy may be observed in pyloric gland mucosa, intestinal metaplasia (IM) was confined to endoscopically detectable lesions in pyloric gland mucosa. All IM lesions were classified as incomplete type and predominantly exhibited a small intestinal‐type differentiation with residual gastric ...
Shinsuke Suemitsu, Kotaro Shibagaki, Asuka Araki, Yoichi Miyaoka, Koichiro Furuta, Tsuyoshi Mishiro, Masahito Aimi, Yusuke Takahashi, Satoshi Kotani, Nobuhiko Fukuba, Norihisa Ishimura, Mamiko Nagase, Shigeru Kawabata, Daisuke Niino, Ryoji Kushima, Shunji Ishihara   +15 more
wiley   +1 more source

The Critical Role of GALNTs‐Regulated O‐GalNAc Glycosylation in Cancer Malignancy

The FASEB Journal, Volume 40, Issue 8, 30 April 2026.
The GALNT family initiates mucin‐type O‐GalNAc glycosylation in the Golgi apparatus and how regulatory mechanisms, including GALNT relocalization and microRNA control, modulate this process. Dysregulated O‐GalNAc glycosylation alters key cellular behaviors and promotes cancer malignancy, highlighting its relevance to tumor progression as well as its ...
Jiahao Liu, Sihan Wu, Ge Zhang, Jiehan Li, Yuhan Yin, Aman Uiiah, Sanfei Peng, Yang Fu   +7 more
wiley   +1 more source

Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation or food restriction [PDF]

, 1978
B. Willms, R. Ebert, W. Creutzfeldt
openalex   +1 more source

Pristimerin ameliorates spasmolytic polypeptide-expressing metaplasia by modulating <i>Cdkn1c</i> (p57)-mediated glycolytic reprogramming. [PDF]

World J Gastroenterol
Wen JS, Pan ZW, Yao XD, Liu YQ, Zhu YD.
europepmc   +1 more source

The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. [PDF]

, 1977
Eli Ipp, Richard Dobbs, V. Harris, Akira Arimura, Wylie Vale, Roger H. Unger   +5 more
openalex   +1 more source

Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum

Gut, 1973
J. Polak, S. Bloom, M. Kuzio, J. Brown, A. Pearse   +4 more
semanticscholar   +1 more source